Arpa Garay - Net Worth and Insider Trading
Arpa Garay Net Worth
The estimated net worth of Arpa Garay is at least $311,269 dollars as of 2023-09-23. Arpa Garay is the Chief Commercial Officer of Moderna Inc and owns about 3,113 shares of Moderna Inc (MRNA) stock worth over $311,269. Details can be seen in Arpa Garay's Latest Holdings Summary section.
Transaction Summary of Arpa Garay
Arpa Garay Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Arpa Garay owns 3 companies in total, including Merck & Co Inc (MRK) , Merck & Co Inc (MRKPRB.PFD) , and Moderna Inc (MRNA) .
Click here to see the complete history of Arpa Garay’s form 4 insider trades.
Insider Ownership Summary of Arpa Garay
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| MRK | Merck & Co Inc | 2022-02-28 | SVP Human Health Global Mktg. |
| MRKPRB.PFD | Merck & Co Inc | 2022-02-28 | SVP Human Health Global Mktg. |
| MRNA | Moderna Inc | 2022-06-28 | Chief Commercial Officer |
Arpa Garay Latest Holdings Summary
Arpa Garay currently owns a total of 1 stock. Arpa Garay owns 3,113 shares of Moderna Inc (MRNA) as of September 6, 2023, with a value of $311,269.
Latest Holdings of Arpa Garay
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| MRNA | Moderna Inc | 2023-09-06 | 3,113 | 99.99 | 311,269 |
Holding Weightings of Arpa Garay
Arpa Garay Form 4 Trading Tracker
According to the SEC Form 4 filings, Arpa Garay has made a total of 2 transactions in Moderna Inc (MRNA) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Moderna Inc is the sale of 574 shares on September 6, 2023, which brought Arpa Garay around $62,222.
Insider Trading History of Arpa Garay
- 1
Arpa Garay Trading Performance
Arpa Garay Ownership Network
Ownership Network List of Arpa Garay
Ownership Network Relation of Arpa Garay
Arpa Garay Owned Company Details
What does Merck & Co Inc do?
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent pediatric diseases as well as human papillomavirus, or HPV. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company's sales are generated in the United States.
Who are the key executives at Merck & Co Inc?
Arpa Garay is the SVP Human Health Global Mktg. of Merck & Co Inc. Other key executives at Merck & Co Inc include President & Human Health Int?l Joseph Romanelli , Chief Marketing Officer Chirfi Guindo , and SVP & U.S. Market Johannes Jacobus Oosthuizen .
Merck & Co Inc (MRK) Insider Trades Summary
Over the past 18 months, Arpa Garay made no insider transaction in Merck & Co Inc (MRK). Other recent insider transactions involving Merck & Co Inc (MRK) include a net sale of 133,401 shares made by Steven Mizell , a net sale of 2,172,853 shares made by Kenneth C Frazier , and a net sale of 4,715 shares made by Joseph Romanelli .
In summary, during the past 3 months, insiders sold 8,839 shares of Merck & Co Inc (MRK) in total and bought 0 shares, with a net sale of 8,839 shares. During the past 18 months, 3,613,019 shares of Merck & Co Inc (MRK) were sold and 409 shares were bought by its insiders, resulting in a net sale of 3,612,610 shares.
Merck & Co Inc (MRK)'s detailed insider trading history can be found in Insider Trading Tracker table.
Merck & Co Inc Insider Transactions
Arpa Garay Mailing Address
Above is the net worth, insider trading, and ownership report for Arpa Garay. You might contact Arpa Garay via mailing address: 2000 Galloping Hill Rd, Kenilworth Nj 07033.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
